Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.14.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DY.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDDSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.53SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.60SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBBSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
A.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KY.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.634SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.11.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.32.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.47.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used